tm logo
APTOFUSE
Live/Registered
REGISTERED

on 07 Feb 2023

Last Applicant/ Owned by

18 rue Robespierre

BEAURAINS

FR

62217

Serial Number

90677150 filed on 28th Apr 2021

Registration Number

6975441 registered on 07th Feb 2023

in the Principal Register

Correspondent Address

Jeff Goehring

Jeff Goehring

901 N. GLEBE ROAD, 11TH FLOOR

ARLINGTON, VA 22203

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

APTOFUSE

Medical, pharmaceutical and surgical products for nucleic acid implants of the spine, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; chemical substances for nucleic implants, namely, carbonate apatite anorganic bone mineral for more optimal resorption and re Read More

Classification Information


Class [005]
Pharmaceutical Products


Medical, pharmaceutical and surgical products for nucleic acid implants of the spine, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; chemical substances for nucleic implants, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; filling substances for nucleic implants, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; bio-absorbable filling substances for nucleic implants, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; injectable viscoelastic substances for nucleic implants, namely, carbonate apatite anorganic bone mineral for more optimal resorption and remodeling due to increased solubility, bioactive glass and highly purified bovine-derived Type I collagen; injectable dermal filler in the nature of biocompatible silicone for nucleic acid implants


First Use Date in General

01st Sep 2022

First Use Date in Commerce

01st Sep 2022

Class [010]
Medical Instrument Products


Surgical nucleic implants for vertebrae; surgical nucleoarthoplasty implants for vertebrae; surgical nucleic implants based on filling substances for vertebrae; surgical implants for intervertebral discs; surgical nucleic implants based on injectable biocompatible silicone; surgical implants for intervertebral discs; surgical implants based on bone substitutes; bone substitutes, intervertebral bone substitutes, allograft bone substitutes, synthetic bone substitutes


First Use Date in General

01st Sep 2022

First Use Date in Commerce

01st Sep 2022

Mark Details


Serial Number

No 90677150

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 7128-0092

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
07th Feb 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
07th Feb 2023REGISTERED-PRINCIPAL REGISTER
06th Jan 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05th Jan 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
21st Dec 2022STATEMENT OF USE PROCESSING COMPLETE
19th Dec 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
01st Dec 2022USE AMENDMENT FILED
01st Dec 2022TEAS STATEMENT OF USE RECEIVED
07th Jun 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12th Apr 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED